Media playback is unsupported on your device

EU-US trade talks: Focus on closer drug licensing collaboration

9 July 2013 Last updated at 10:11 BST

Trade negotiators are locked away in a room in Washington, poring over the details of a huge trans-Atlantic trade deal between the US and EU.

One of the aims of these talks is to make it easier for medicines licensed on one side of the Atlantic to be given the green light on the other.

Currently a drug approved for use in America could take two years or more before being approved in Europe, and vice-versa.

Jeremy Howell reports.

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.